Australian cannabis pharmaceuticals company THC Global (ASX: THC) is one major step closer to their ‘Farm to Pharma’ strategy, having been granted a Manufacture Permit from the Australian Office of Drug Control for their facility in Southport, Queensland. By securing the permit, THC Global will immediately commence production of medicinal cannabis products which have been
Read More
Australian payments technology innovator Novatti (ASX: NOV) has secured a significant backing with Australian Fintech Investment Group (AFIG) to invest $1.1m in Novatti’s ambitious disruption plans which will initially target new migrants. The investment will be made directly into Novatti B Holding Company (NBHC) which will be the subsidiary managing the company’s banking services unit,
Read More
Australian bio-pharmaceutical developer Zelda Therapeutics (ASX: ZLD) has now fully enrolled insomnia sufferers into clinical trials where the Company aims to use cannabis as a treatment for clinically diagnosed patients. This set of trials will be completed in collaboration with the University of Western Australia (UWA) Centre for Sleep Science. The trials will aim to
Read More
Organic food producer Murray River Organics Group (ASX: MRG) has seen a 27% uplift in exports. Interest from China-based consumers have led the drive, following the Company’s marketing tactics using the WeChat social media platform. Using WeChat, Murray River Organics has been able to communicate directly with consumers at a time when ongoing food safety
Read More
The recent failures of IPO hopefuls WeWork and Latitude Financial have brought the magnifying glass upon the longstanding IPO process itself. The traditional IPO hasn’t changed for quite some time, and with the way things are going, a breaking point could be on the horizon as private investors get increasingly frustrated. The alternative being discussed
Read More
